NEW YORK, April 11 (GenomeWeb News) - Invitrogen and Signalomics of Germany will collaborate to develop nanocrystal reagents for cancer diagnostics, Invitrogen said today.

 

Initially, the partners want to develop an imaging agent that can be used to identify colon carcinomas that require surgery.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.